309 related articles for article (PubMed ID: 14677678)
21. The eradication of foot-and-mouth disease: a parallel problem.
Brown F
Dev Biol (Basel); 2001; 105():123-7; discussion 149-50. PubMed ID: 11763321
[TBL] [Abstract][Full Text] [Related]
22. [Conclusions from the outbreak of foot-and-mouth disease in the government district of Hannover in 1987/1988].
Strohmaier K
Dtsch Tierarztl Wochenschr; 1990 May; 97(5):210-2. PubMed ID: 2194777
[TBL] [Abstract][Full Text] [Related]
23. Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America.
Malirat V; de Barros JJ; Bergmann IE; Campos Rde M; Neitzert E; da Costa EV; da Silva EE; Falczuk AJ; Pinheiro DS; de Vergara N; Cirvera JL; Maradei E; Di Landro R
Virus Res; 2007 Mar; 124(1-2):22-8. PubMed ID: 17056146
[TBL] [Abstract][Full Text] [Related]
24. Selection of foot and mouth disease vaccine strains--a review.
Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
[TBL] [Abstract][Full Text] [Related]
25. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
26. Current Status and Future Prospects to Achieve Foot-and-Mouth Disease Eradication in South America.
Clavijo A; Sanchez-Vazquez MJ; Buzanovsky LP; Martini M; Pompei JC; Cosivi O
Transbound Emerg Dis; 2017 Feb; 64(1):31-36. PubMed ID: 25754249
[TBL] [Abstract][Full Text] [Related]
27. Foot-and-mouth disease control using vaccination: South African experience.
Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
[TBL] [Abstract][Full Text] [Related]
28. [Vaccination against foot and mouth disease: current state and perspectives].
Visser N; Thiel HJ
Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
[TBL] [Abstract][Full Text] [Related]
29. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.
Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N
Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662
[TBL] [Abstract][Full Text] [Related]
30. [Expression of foot and mouth disease virus antigens in transgenic plants].
Dus Santos MJ; Wigdorovitz A
Rev Sci Tech; 2005 Apr; 24(1):175-87. PubMed ID: 16110887
[TBL] [Abstract][Full Text] [Related]
31. How to promote joint participation of the public and private sectors in the organisation of animal health programmes.
Melo EC; Saraiva V
Rev Sci Tech; 2003 Aug; 22(2):517-22. PubMed ID: 15884587
[TBL] [Abstract][Full Text] [Related]
32. Elimination of foot-and-mouth disease in South America: lessons and challenges.
Naranjo J; Cosivi O
Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120381. PubMed ID: 23798699
[TBL] [Abstract][Full Text] [Related]
33. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
34. Global situation of foot-and-mouth disease (FMD)--a short review.
Kesy A
Pol J Vet Sci; 2002; 5(4):283-7. PubMed ID: 12512564
[TBL] [Abstract][Full Text] [Related]
35. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
36. Identification of foot-and-mouth disease virus-free regions by use of a standardized enzyme-linked immunoelectrotransfer blot assay.
Bergmann IE; Malirat V; Dias LE; Dilandro R
Am J Vet Res; 1996 Jul; 57(7):972-4. PubMed ID: 8807005
[TBL] [Abstract][Full Text] [Related]
37. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
Roth JA
Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
[TBL] [Abstract][Full Text] [Related]
38. Novel approaches to foot-and-mouth disease vaccine development.
Ludi A; Rodriguez L
Dev Biol (Basel); 2013; 135():107-16. PubMed ID: 23689888
[TBL] [Abstract][Full Text] [Related]
39. The application of biotechnology to the control of foot-and-mouth disease virus.
Kitching RP
Br Vet J; 1992; 148(5):375-88. PubMed ID: 1330200
[TBL] [Abstract][Full Text] [Related]
40. Modelling vaccination strategies against foot-and-mouth disease.
Keeling MJ; Woolhouse ME; May RM; Davies G; Grenfell BT
Nature; 2003 Jan; 421(6919):136-42. PubMed ID: 12508120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
